Rocket Pharmaceuticals
Business Services · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
9 Cedarbrook Dr, Cranbury, New Jersey, 0...Phone Number
(646) 440-9100Website
www.rocketpharma.comRevenue
-Stock Symbol
RCKTIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
4
1
2
About Rocket Pharmaceuticals
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing innovative gene therapies for rare and serious genetic diseases. The company focuses on addressing unmet medical needs through advanced research in genetic medicine, particularly targeting conditions that currently have limited or no treatment options. With a strong emphasis on scientific innovation, Rocket Pharmaceuticals pursues programs that span from preclinical research to clinical development, aiming to bring transformative therapies to patients. The organization operates across multiple locations, maintaining a collaborative environment that integrates cutting-edge research with strategic development efforts, positioning itself at the forefront of the gene therapy field.Explore more
Rocket Pharmaceuticals Org Chart
EZ
Global Senior VP, Development Operations & Pr...
JP
Vice President, Technical Operations
DG
Head Vice President, Quality
AM
Global Associate VP, Supply Chain
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rocket Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Rocket Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Rocket Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Rocket Pharmaceuticals has new funding data
Rocket Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Rocket Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Rocket Pharmaceuticals launches new products
Check out if Rocket Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Rocket Pharmaceuticals recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Rocket Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Rocket Pharmaceuticals
Compare insights from companies similar to Rocket Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Rocket Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Rocket Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Rocket Pharmaceuticals.
Rocket Pharmaceuticals financials insights
Gather financial insights about Rocket Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$16.4M
2017
Private Equity
$25.1M
2021
Share Placement
$26.4M
Rocket Pharmaceuticals Tech Stack
A closer look at the technologies used by Rocket Pharmaceuticals
See more technologies
Most Recent Scoops
Person-Based
Earnings, Pharmaceuticals, Finance
Person-Based
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Product Launch, Pharmaceuticals
Project
Laboratory Operations, Medical Research, Clinical Operations
Rocket Pharmaceuticals News & Media
Rocket Pharmaceuticals (RCKT) Reports Q1 2026 Net Loss of $47.6M
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best NASDAQ stocks under $5 to buy right now. On May 7, Rocket Pharmaceuticals reported a Q1 2026 net loss of $47.6 million ($0.42 per share). Driven by a recent realignment and lower headcount, R&D expenses fell to $31.5 million, and G&A expenses dropped to $17.1 million. […]Why Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) is one of the penny stocks with the potential to rise 1000 percent. On March 27, Rocket Pharmaceuticals said the FDA approved KRESLADI for a rare pediatric disorder, giving the company its first marketed product and a key regulatory win after a long review path. The company said the approval also […]Rocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 Transcript
Rocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 March 27, 2026 8:30 AM...Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best single digit stocks to buy according to analysts. On January 8, Morgan Stanley lowered its price target for Rocket Pharmaceuticals from $7 to $5 while keeping an Equal Weight rating. In a 2026 group outlook, the firm noted it expects continued outperformance for US small-to-mid cap […]
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rocket Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing innovative gene therapies for rare and serious genetic diseases. The company focuses on addressing unmet medical needs through advanced research in genetic medicine, particularly targeting conditions that currently have limited or no treatment options. Wi... Read More
